Newsletter
Search
Indian Markets Gain on a Fresh Round of Optimism of War End
India's benchmarks were much higher on the first day of the fiscal year after a very bruising March
India Can Make Any Drug. What Will It Take to Invent a First-in-Class Molecule?
The industry that flooded the world with semaglutide on the same day it went generic has yet to invent a first-in-class drug that sells globally.
Why the Iran Conflict will Last Longer than Generally Expected
Insights into how the West Asia Conflict could reshape markets, energy dynamics and the global balance of power.
Fresh Misdirection from the US on a Possible End to The War
The US now has troops on ground who are presumably raring to go
Law Firms Won’t Solve HDFC Bank’s ‘Governance Plus’ Issues
While HDFC Bank received a clean chit from the Reserve Bank of India after Atanu Chakraborty’s resignation and has gotten external law firms to oversee its governance standards, it may not be enough.
Ashish Pherwani On The Big Trends Driving India’s ₹2.7 Trillion Media And Entertainment Industry
Digital Media Tops ₹1 Lakh Crore in India’s M&E Sector
Sensex Hits Two Year Low as Oil Crosses $115 per Barrel
Oil prices are falling and Iran is being bombed relentlessly as targets are now being expanded to include civilians
Rental Hurdles, Structural Gaps Stand Amid Govt’s Aggressive PNG Push
India’s mandated PNG shift faces a test as the West Asia gas crisis collides with entrenched rental hurdles, critical capex bottlenecks, and deep psychological barriers.
